It’s been a few years since we last spoke. Can you give our readers a refresher on the company and its history? Dr. Bedu-Addo: So, PDS Biotechnology is developing immunotherapies that train the immune ...

"We are also seeing improvement in US biotech funding, as well as higher M&A and IPO activity, which are leading indicators ...

Alan H. Auerbach has served as Chairman of the Board and as CEO and President of Puma Biotechnology, Inc. since its inception. Before joining Puma, Mr. Auerbach served as Founder, CEO, President and a ...

In the fast-paced world of biotechnology, success hinges on more than groundbreaking science—it requires the right connections, strategic partnerships, and access to capital. Biotech Showcase delivers ...

We hope Eli Lilly can present a key solution to South Korea’s vision of emerging as a global top-five biotech powerhouse. Lilly, too, will further secure access to innovative drugs that could be ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.